Table 1.
Control (n = 10) | Cisplatin treated (n = 10) | PRP treated (n = 10) | H | p | |
---|---|---|---|---|---|
Change in plasma creatinine level | |||||
Min.–Max. | −0.21–0.10 | 0.16–2.20 | −0.15–0.20 | 19.665* | <0.001* |
Mean ± SD. | −0.04 ± 0.12 | 1.17 ± 0.59 | 0.03 ± 0.11 | ||
Median | −0.04 | 1.16 | 0.0 | ||
p1 | <0.001* | 0.358 | |||
p2 | 0.001* | ||||
Change in urea level | |||||
Min.–Max. | −3.0–5.0 | 32.0–107.0 | −12.0–32.0 | 21.422* | <0.001* |
Mean ± SD. | 0.80 ± 2.97 | 71.40 ± 22.17 | 13.60 ± 13.80 | ||
Median | 1.0 | 72.0 | 16.50 | ||
p1 | <0.001* | 0.137 | |||
p2 | 0.002* |
SD, standard deviation
H, H for Kruskal-Wallis test, pairwise comparison bet. each 2 groups was done using post hoc test (Dunn’s for multiple comparisons test)
p, p value for comparing between the three studied groups
p1, p value for comparing between control and each other groups
p2, p value for comparing between cisplatin-treated and PRP-treated
*Statistically significant at p ≤ 0.05